Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2115-2025

Access Vitamin B12 Reagent, Catalog Number 33000, Lot Number 439850 Recall

Access Vitamin B12 Reagent, Catalog Number 33000, Lot Number 439850

FDA recall Class II

Completed

FDA lists this Class II recall for Access Vitamin B12 Reagent, Catalog Number 33000, Lot Number 439850. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2115-2025
Recall classification
Class II
Enforcement status
Completed
Initiation date
Feb 27, 2025
FDA report date
Jul 23, 2025
Quantity in commerce
10,000 units
Distribution
See key details
FDA cause
Process control

What is being recalled?

Access Vitamin B12 Reagent, Catalog Number 33000, Lot Number 439850

Affected model & UDI checker

Search the exact identifiers published for Z-2115-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
33000Access Vitamin B12 Reagent, Catalog Number 33000, Lot Number 439850Check source noticeNot specified
Not specifiedAccess Vitamin B12 Reagent, Catalog Number 33000, Lot Number 439850Check source notice15099590224301
FDA code information

UDI-DI: 15099590224301; Lot Number: 439850

View the original FDA recall notice

Why was this product recalled?

Beckman Coulter has received complaints of erroneous Vitamin B12 results when using Access Vitamin B12 Reagent lot 439850. The affected reagent lot may cause erroneously low or high Vitamin B12 results, leading to a delayed or improper diagnosis and/or repeat testing.

What actions did BECKMAN COULTER, INC. take?

An URGENT MEDICAL DEVICE RECALL notification letter dated 2/19/25 was sent to customers. ACTION: Discontinue using Access Vitamin B12 reagent lot 439850. Discard all remaining reagent packs from this lot following your laboratory procedures. Beckman Coulter recommends sharing the content of this letter with your laboratory and/or medical director regarding the need to review previous patient results. Contact your local Beckman Coulter representative for replacement product requests. Please share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. If you have forwarded any of the affected product listed above to another laboratory, please provide them a copy of this letter. So that we are assured you have received this important communication, please respond within 10 days in one of the following ways: Electronically, if you received this communication via email. Manually, complete and return the enclosed Response Form. If you have any questions regarding this notice, please contact our Customer Support Center: From our website: http://www.beckmancoulter.com You may request replacement product by contacting your local Beckman Coulter Representative for replacement.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology